James Mond

2019

In 2019, James Mond earned a total compensation of $1.2M as Executive Vice President, Chief Scientific Officer and Chief Medical Officer at ADMA Biologics, a 18% increase compared to previous year.

Compensation breakdown

Bonus$207,500
Option Awards$380,429
Salary$415,000
Other$234,493
Total$1,237,422

Mond received $415K in salary, accounting for 34% of the total pay in 2019.

Mond also received $207.5K in bonus, $380.4K in option awards and $234.5K in other compensation.

Rankings

In 2019, James Mond's compensation ranked 8,273rd out of 13,971 executives tracked by ExecPay. In other words, Mond earned more than 40.8% of executives.

ClassificationRankingPercentile
All
8,273
out of 13,971
41st
Division
Manufacturing
3,266
out of 5,692
43rd
Major group
Chemicals And Allied Products
1,234
out of 2,189
44th
Industry group
Drugs
1,048
out of 1,875
44th
Industry
Biological Products, Except Diagnostic Substances
238
out of 389
39th
Source: SEC filing on April 29, 2020.

Mond's colleagues

We found two more compensation records of executives who worked with James Mond at ADMA Biologics in 2019.

2019

Adam Grossman

ADMA Biologics

Chief Executive Officer

2019

Brian Lenz

ADMA Biologics

Chief Financial Officer

News

You may also like